AXSOME THERAPEUTICS, INC. (AXSM) /
The cash flow of AXSOME THERAPEUTICS, INC. over the past 10 years
Chart AXSOME THERAPEUTICS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, AXSOME THERAPEUTICS, INC.'s operating cash flow was -$93.41M and its capital expenditures $480K, leaving free cash flow of -$93.89M. Free cash flow was below zero in all 10 years shown. It ranged from -$145.66M in fiscal 2023 to -$21.39M in fiscal 2016. Capital expenditures were highest in fiscal 2022, at $702K.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$93.41M | $480K | -$93.89M |
| 2024ended Dec 31, 2024 | -$128.41M | $270K | -$128.68M |
| 2023ended Dec 31, 2023 | -$145.08M | $582K | -$145.66M |
| 2022ended Dec 31, 2022 | -$116.51M | $702K | -$117.21M |
| 2021ended Dec 31, 2021 | -$108.23M | $308K | -$108.53M |
| 2020ended Dec 31, 2020 | -$78.46M | $45.89K | -$78.5M |
| 2019ended Dec 31, 2019 | -$46.38M | $16.12K | -$46.39M |
| 2018ended Dec 31, 2018 | -$30.05M | $32.7K | -$30.09M |
| 2017ended Dec 31, 2017 | -$26.47M | $9.9K | -$26.48M |
| 2016ended Dec 31, 2016 | -$21.28M | $104.56K | -$21.39M |
Fiscal years as AXSOME THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AXSOME THERAPEUTICS, INC.
- The revenue of AXSOME THERAPEUTICS, INC.
- The profitability of AXSOME THERAPEUTICS, INC.
- The debt of AXSOME THERAPEUTICS, INC.
- All of AXSOME THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- AGCOAGCO CORP /DE
- APPFAppFolio, Inc.
- ALKSAlkermes plc.
- URBNUrban Outfitters, Inc.
- SSDSimpson Manufacturing Co., Inc.
Not investment advice. This page shows what AXSOME THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.